Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this interventional study is to evaluate the efficacy and tolerability of
docosahexaenoic acid (DHA) in children or adolescents with well-characterized and liver
biopsy confirmed nonalcoholic fatty liver disease (NAFLD).